Press

Ventilator Boost for Regions   As printed in The Advertiser, Thursday 30th April 2020 By Charles Miranda ADELAIDE scientists have helped create a groundbreaking “field ventilator” to combat coronavirus in remote regions across Australia and overseas. And the device will go into production in Australia, which means no issues with...

As printed in The Herald Sun Friday, 1st May 2020 By Miranda Devine & Charles Miranda A VICTORIAN biotech company awarded a $31 million federal contract to build Australian-made ventilators for coronavirus patients has admitted multiple components will be sourced overseas, including from China. And the crucial section...

4DX chief executive and founder Andreas Fouras. Picture: Roy VanDerVegt   Posted on The Australian, 11 March 2020 An Australian medical technology company is hoping to forge the pathway to a fast-tracked coronavirus diagnosis by reducing the ­diagnostic time to three hours. 4DX is seeking to partner with an...

  4Dx in the news!  Check out the latest article on our technology on the Mirage News website: https://www.miragenews.com/second-wind-new-technology-to-help-diagnose-and-manage-respiratory-diseases/...

[vc_row][vc_column][vc_column_text]A new Stockhead article was posted yesterday naming 4Dx as one of six Australian IPOs to watch for in 2020. See below for the article text, or click HERE to read directly from Stockhead's website. Thank you, Stockhead!   4Dx 4Dx is a med-tech with a lung imaging platform. It...

New news releases from BioMelbourne Network and Biotech Daily, Dec. 10, 2019: (https://biotechdispatch.com.au/news/4dx-raises-15m-in-oversubscribed-capital-raise)   ****************** 10 December 2019 Melbourne, Australia: Australian medical technology company 4Dx Limited has raised $15 million in a heavily oversubscribed pre-IPO. The funds raised via the unsecured converting note issue will be used to drive 4Dx’s go-to-market...

From Biotech Daily - released Friday, November 1, 2019   4DX LIMITED 4DX says a 32-patient, 13-month study shows that its XV technology is superior to “gold standard pulmonary diagnostics” to measure lung health. 4DX said the study, titled ‘Novel x-ray velocimetry based quantitative regional lung function analysis to...

A new article was posted today on Stockhead.com, an online health & technology news service focusing on big discoveries, medical breakthroughs and revolutionary technologies. [button size='' style='' text='Check it out!' icon='' icon_color='' link='https://stockhead.com.au/health/4dxs-lung-imaging-technology-just-passed-a-clinical-trial-next-step-an-asx-listing/' target='_blank' color='' hover_color='' border_color='' hover_border_color='' background_color='' hover_background_color='' font_style='' font_weight='' text_align='' margin='']...

Headquartered in Westlake Village, CA, 4DX developed a medical technology that has the capacity to simply, safely, and effectively view lung air flow function in fine detail.   Andreas Fouras, CEO of 4DX, and a mechanical engineer by training, is behind this innovation. While working at a...

Advanced software reduces dose without sacrificing image quality.   Although the direct health risk of medical diagnostic scanning is not unequivocally clear, it is important for patients as well as health care professionals to mitigate the risks of radiation dose. While most of the concern regarding overexposure...